Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer. [electronic resource]
Producer: 20160526Description: 669-74 p. digitalISSN:- 1868-6982
- Aged
- Antineoplastic Agents -- administration & dosage
- Biliary Tract Neoplasms -- diagnosis
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Combinations
- Female
- Follow-Up Studies
- Humans
- Japan -- epidemiology
- Male
- Middle Aged
- Neoplasm Staging
- Oxonic Acid -- administration & dosage
- Retrospective Studies
- Survival Rate -- trends
- Tegafur -- administration & dosage
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.